Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 1.00 |
| ▸ | RXRB | P28702 | 1/20 | 1.00 |
| ▸ | RXRG | P48443 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.50 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.50 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.50 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopimaric Acid SCHEMBL234276 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL13702083 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL15339339 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL2603438 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL12732275 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL15744755 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL4549113 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Sandaracopimaric Acid SCHEMBL3894069 | 0.89 | RXRA (0.80) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| SCHEMBL31390163 | 0.88 | RXRA (0.78) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| SCHEMBL17891641 | 0.87 | RXRA (0.77) | RXRARXRBRXRGCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220168230-A1 | NANOPARTICLE MEDIATED THERAPY | YALE UNIVERSITY | 2022-06-02 | — | — | US | disclosed |
| US-20200214989-A1 | NANOMATERIALS WITH ENHANCED DRUG DELIVERY EFFICIENCY | YALE UNIVERSITY | 2020-07-09 | — | — | US | disclosed |
| US-20140148572-A1 | PIMARIC TYPE RESIN ACID PRODUCT, AND METHOD OF PREPARING THE SAME | Institute of Chemical Industry of Forest Products, CAF (CN) | 2014-05-29 | — | — | US | disclosed |
| US-20140148572-A1 | PIMARIC TYPE RESIN ACID PRODUCT, AND METHOD OF PREPARING THE SAME | Institute of Chemical Industry of Forest Products, CAF (CN) | 2014-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200214989-A1 | NANOMATERIALS WITH ENHANCED DRUG DELIVERY EFFICIENCY | VIP, SI, LSS | RXRA 101/4885RXRB 257/4885RXRG 200/4885 |
| US-20220168230-A1 | NANOPARTICLE MEDIATED THERAPY | LSS, CYP46A1, CYP51A1 | RXRA 483/4885RXRB 992/4885RXRG 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.